FDA New Strategy To Replace Animal Testing: The Future of Drug Development is Human-Centered and Tech-Driven
In a groundbreaking move towards more ethical and efficient drug development, the U.S. Food and Drug Administration (FDA) has announced a significant shift away from animal testing in the creation of monoclonal antibody therapies and other medications. This bold strategy promises to revolutionize how drugs are developed, evaluated, and brought to market, marking a new era where human-relevant methods take the lead.
FDA's Game-Changing Animal Health Agenda: What It Means for Veterinarians
In September 2023, the FDA released the Animal and Veterinary Innovation Agenda (AVIA) to drive innovation in animal health. The agenda aims to support veterinarians, pet owners, agricultural producers, and public health programs by fostering advancements in technologies and products. The AVIA outlines four key objectives to enhance regulatory pathways, prioritize high-need areas, strengthen the One Health workforce, and address emerging health threats, ensuring the availability of safe and effective animal health products.